Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Immune-mediated inflammation of the pituitary gland often associated with other autoimmune diseases (e.g., hashimoto disease; graves disease; and addison disease).
Biomarker and diagnostic research for primary hypophysitis has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for primary hypophysitis.
68 publications have been identified in PubMed for primary hypophysitis. Research spans Case Report / Case Series (53%), Review / Meta-Analysis (29%), and Diagnostic / Biomarker (6%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 36 | 53% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 4:44 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
20 |
29% |
Testing and diagnosis research | 4 | 6% |
Other research | 3 | 4% |
Disease patterns and progression | 2 | 3% |
Clinical study results | 1 | 1% |
Laboratory research | 1 | 1% |
New treatment approaches | 1 | 1% |
Fukuta T (2026). [PMID: 41509149](https://pubmed.ncbi.nlm.nih.gov/41509149/). *Clin Pediatr Endocrinol*. [Case Report / Case Series]
Xu T (2026). [PMID: 41961371](https://pubmed.ncbi.nlm.nih.gov/41961371/). *J Endocrinol Invest*. [Review / Meta-Analysis]
Sahin S (2026). [PMID: 42171668](https://pubmed.ncbi.nlm.nih.gov/42171668/). *J Endocrinol Invest*. [Diagnostic / Biomarker]
Urai S (2026). [PMID: 42189480](https://pubmed.ncbi.nlm.nih.gov/42189480/). *J Endocrinol Invest*. [Gene Therapy / Novel Therapeutics]
Iglesias P (2026). [PMID: 42123046](https://pubmed.ncbi.nlm.nih.gov/42123046/). *J Clin Med*. [Review / Meta-Analysis]
Lam JR (2026). [PMID: 32965926](https://pubmed.ncbi.nlm.nih.gov/32965926/). *Unknown Journal*. [Review / Meta-Analysis]
Caputo C (2026). [PMID: 41397897](https://pubmed.ncbi.nlm.nih.gov/41397897/). *Pathology*. [Review / Meta-Analysis]
Kim S (2026). [PMID: 41488996](https://pubmed.ncbi.nlm.nih.gov/41488996/). *Endocr Connect*. [Review / Meta-Analysis]
Czechowski A (2026). [PMID: 42100866](https://pubmed.ncbi.nlm.nih.gov/42100866/). *Pol Arch Intern Med*. [Case Report / Case Series]
Turin CG (2026). [PMID: 41317043](https://pubmed.ncbi.nlm.nih.gov/41317043/). *J Neuropathol Exp Neurol*. [Review / Meta-Analysis]
AI-curated news mentioning primary hypophysitis
Updated Aug 3, 2026
A systematic review highlights the clinical, radiological, and endocrine features of lupus-associated hypophysitis. This condition, linked to systemic lupus erythematosus, presents unique challenges in diagnosis and management.